The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia
- 1 April 1989
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 62 (02) , 797-801
- https://doi.org/10.1055/s-0038-1646906
Abstract
Plasma lipids and haemostasis were investigated in 17 patients with hyperlipidaemia before and after 6 weeks supplementation with 6 g n-3 fatty acids. Nine of the patients had type IIa and 8 had type IV hyperlipidaemia. No effect on plasma cholesterol, LDL- or HDL-cholesterol were seen, but plasma triglycerides decreased after n-3 supplementation. Apolipoprotein B increased and apolipoprotein A1 decreased after the oil supplement. The bleeding time was prolonged, but platelet aggregation was unaltered by n-3 fatty acids. Protein C activity increased in type II a and decreased in type IV after the supplement. Fibrinolysis was markedly depressed while von Willebrand factor antigen was reduced after intake of n-3 fatty acids.Keywords
This publication has 28 references indexed in Scilit:
- COAGULATION FACTORS AND THE PROGRESS OF CORONARY HEART DISEASEThe Lancet, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Increased platelet sensitivity and thromboxane B2 formation in type‐II hyperlipoproteinaemic patientsEuropean Journal of Clinical Investigation, 1984
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITYThe Lancet, 1983
- Hyperlipoproteinaemia and Reduced Fibrinolytic Activity in Healthy Coronary High‐Risk MenActa Medica Scandinavica, 1981
- Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemiaThrombosis Research, 1979